Medical aesthetics platform So-Young International's Q3 revenue up 4% on center expansion

Reuters
4 hours ago
Medical aesthetics platform So-Young International's Q3 revenue up 4% on center expansion

Overview

  • So-Young Q3 revenue rises 4% yr/yr to RMB386.7 mln ($54.3 million), driven by center expansion

  • Company reports Q3 net loss of RMB64.3 mln, compared to net income last year

  • Verified treatment visits and aesthetic treatments performed increased significantly

Outlook

  • Company expects Q4 2025 aesthetic treatment services revenue between RMB216 mln and RMB226 mln

Result Drivers

  • CENTER EXPANSION - Revenue growth driven by expansion of branded aesthetic centers

  • TREATMENT SERVICES GROWTH - Aesthetic treatment services revenue surged 304.6% due to center expansion

  • USER ENGAGEMENT - Verified treatment visits and aesthetic treatments performed increased significantly

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

RMB 386.67 mln

Q3 Net Income

-RMB 64.84 mln

Q3 Gross Profit

RMB 182.87 mln

Q3 Operating Expenses

-RMB 255.58 mln

Analyst Coverage

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the online services peer group is "buy."

  • Wall Street's median 12-month price target for So-Young International Inc is $7.89, about 53.5% above its November 14 closing price of $3.67

Press Release: ID:nPn602N2fa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10